Investors

2018 News

Keyword Search
 
2018 | 2017 | 2016 | 2015 | 2014
DateTitle 
02/07/18Forward Pharma to Present at the 7th Annual Leerink Partners Global Healthcare Conference
COPENHAGEN, Denmark, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (the “Company”) today announced that Dr. Claus Bo Svendsen, the Company’s Chief Executive Officer, will give a corporate update at the 7th Annual Leerink Partners Global Healthcare Conference in New York, NY. Dr. Svendsen will present on Thursday, February 15, 2018 at 10:30 AM ET and host one-on-one meetings. Investors and other interested parties may access a live audio webcast of our conference presentati... 
Printer Friendly Version
01/29/18Forward Pharma Announces the Decision of the European Patent Office in the Opposition Proceedings for the EP2801355 Patent
Forward Pharma Expects to Appeal the Decision Upon Review COPENHAGEN, Denmark, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“Forward” or the “Company”) today announced that the European Patent Office (the “EPO”) has revoked the EP2801355 patent (the “’355 patent”) following the oral hearing in the Opposition Proceedings. The EPO Opposition Division revoked the ’355 patent after considering third-party oppositions from several opponents. The Opposition Division will is... 
Printer Friendly Version